Can someone be diagnosed with PCOS without visible cysts on ultrasound? 

Polycystic Ovary Syndrome (PCOS) is a common hormonal condition that affects how a woman’s ovaries work, but the presence of visible cysts is not a universal requirement for a clinical diagnosis. While the name of the syndrome implies the presence of many cysts, these are actually small, underdeveloped follicles that are often a symptom rather than the definitive cause of the disorder. In the United Kingdom, healthcare professionals follow specific diagnostic frameworks that allow for a diagnosis based on other key clinical and biochemical indicators. This systemic approach ensures that individuals experiencing hormonal or reproductive symptoms receive the necessary care even if their medical imaging appears normal. 

What We’ll Discuss in This Article 

• The application of the Rotterdam criteria in the United Kingdom medical system. 

• How clinical and biochemical signs of high androgens can confirm a diagnosis. 

• The importance of menstrual history and identifying irregular ovulation. 

• Why ultrasound imaging is considered an optional component in many cases. 

• The specific circumstances where ultrasound scans may be avoided or restricted. 

• How other medical conditions are ruled out before confirming a PCOS diagnosis. 

• The role of metabolic screening in identifying the broader impacts of the syndrome. 

The Rotterdam Criteria and the Two out of Three Rule 

In the United Kingdom, the standard method for identifying Polycystic Ovary Syndrome is the application of the Rotterdam criteria. These guidelines, which are supported by NICE, establish that a diagnosis can be made if a patient meets at least two of three specific markers. The first marker is irregular or absent periods, which suggests that the ovaries are not regularly releasing eggs. The second is evidence of high androgen levels, which can be identified through physical signs like excess hair or through blood tests. The third is the appearance of polycystic ovaries on an ultrasound scan. 

Because only two of these three features are required, it is entirely possible for a patient to be diagnosed with PCOS without having any visible follicles or cysts on an ultrasound. For example, if a woman has irregular menstrual cycles and blood tests showing elevated testosterone, she meets the criteria for a diagnosis regardless of what a scan might show. This “two out of three” rule is essential because PCOS is a spectrum disorder, and not every individual will manifest every single symptom. In clinical practice, the focus is often on the internal hormonal balance and external physical signs rather than relying solely on medical imaging. 

Understanding Clinical and Biochemical Hyperandrogenism 

Hyperandrogenism refers to an excess of male hormones, such as testosterone, in the female body. This is a primary feature of PCOS and can be identified in two ways: clinically or biochemically. Clinical hyperandrogenism involves the observation of physical signs that suggest high androgen levels. The most common sign is hirsutism, which is the growth of coarse, dark hair in areas where men typically have hair, such as the face, chest, or back. Other clinical signs include persistent adult acne and thinning hair on the scalp. 

Biochemical hyperandrogenism is identified through blood tests that measure the levels of free or total testosterone in the circulation. Doctors may also check the Free Androgen Index, which calculates the ratio of testosterone to Sex Hormone Binding Globulin (SHBG). In many cases, if these biochemical markers are elevated and the patient also has irregular periods, an ultrasound is deemed unnecessary for a formal diagnosis. This is because the combination of reproductive and hormonal evidence is strong enough to confirm the condition under UK clinical standards. 

Why Ultrasound is Sometimes Omitted or Inconclusive 

Ultrasound imaging is a valuable tool, but it is not infallible or always required. In some instances, a transabdominal scan may not provide a clear enough image of the ovaries to accurately count the small follicles. While a transvaginal scan offers more detail, it may still fail to show the classic “string of pearls” appearance if the condition is in an early stage or if the patient’s hormonal profile is currently stable. Furthermore, the NHS states that many women have polycystic ovaries on a scan but do not have the syndrome, while others have the syndrome with normal looking ovaries. 

For many women, the primary reason for avoiding a scan is that a diagnosis has already been reached through other means. If the clinical and biochemical criteria are met, adding an ultrasound does not change the diagnosis or the management plan. Therefore, some GPs may choose to omit the scan to avoid unnecessary medical procedures. The focus remains on managing the symptoms and protecting long term metabolic health rather than confirming a visual finding that may not be present in every case. 

Excluding Other Medical Conditions 

A crucial part of the diagnostic journey is ensuring that the symptoms are truly caused by PCOS and not another underlying health issue. Many other conditions can cause irregular periods and high androgen levels, such as thyroid disorders, high prolactin levels, or congenital adrenal hyperplasia. In the UK, doctors perform specific blood tests to rule out these possibilities before confirming a diagnosis of PCOS. 

For instance, a Thyroid Stimulating Hormone (TSH) test is used to check thyroid function, while a prolactin test checks for issues with the pituitary gland. If these tests are normal and the patient meets the Rotterdam criteria, the diagnosis is confirmed as PCOS. This process of exclusion is vital because it ensures that patients receive the correct treatment for their specific condition. Because PCOS is a “diagnosis of exclusion,” the thoroughness of the initial blood tests is often more important than the visual findings of an ultrasound scan. 

Comparative Summary of Diagnostic Markers 

Diagnostic Marker	Identification Method	Role in Diagnosis
Irregular Periods	Menstrual history tracking	One of the primary 3 criteria
High Androgens (Clinical)	Observation of hair or acne	One of the primary 3 criteria
High Androgens (Biochemical)	Testosterone blood test	One of the primary 3 criteria
Polycystic Ovaries	Pelvic ultrasound scan	One of the primary 3 criteria
Thyroid Dysfunction	TSH blood test	Used to rule out other causes
High Prolactin	Prolactin blood test	Used to rule out other causes
Insulin Resistance	Glucose or HbA1c test	Assesses metabolic health risk

Conclusion 

A diagnosis of PCOS does not require the presence of visible cysts or follicles on an ultrasound scan, as the condition is defined by a broader set of hormonal and reproductive markers. By meeting two out of the three Rotterdam criteria, such as irregular periods and signs of high testosterone, an individual can be accurately diagnosed and supported. The systemic nature of the syndrome means that clinical and biochemical evidence is often more important than medical imaging, especially in younger populations. Understanding that the syndrome manifests differently in everyone allows for a more personalized and effective approach to management. If you experience severe, sudden, or worsening symptoms, call 999 immediately. 

Authority Snapshot 

This article provides an evidence based overview of the diagnostic process for Polycystic Ovary Syndrome, specifically addressing the role of ultrasound imaging. Dr. Rebecca Fernandez has reviewed the content to ensure it aligns with the clinical standards and diagnostic frameworks used by the NHS and NICE in the United Kingdom. All information provided is strictly intended for patient education and is grounded in official medical guidance to ensure accuracy and safety for all readers.